L’Or\u00e9al akciju v\u0113rt\u012bba samazin\u0101s, uz\u0146\u0113mumam veicot likmes uz Galderma un zin\u0101tniski balst\u012btu \u0101das kop\u0161anu<\/p>\n
Fran\u010du skaistumkop\u0161anas gigants L’Or\u00e9al piedz\u012bvojis nelielu akciju v\u0113rt\u012bbas kritumu Par\u012bzes bir\u017e\u0101, gandr\u012bz par 1,5% samazinoties t\u0101s v\u0113rt\u012bbai r\u012bta tirdzniec\u012bbas sesij\u0101. \u0160is notikums sakr\u012bt ar uz\u0146\u0113muma pazi\u0146ojumu par savas da\u013cas palielin\u0101\u0161anu \u0160veices \u0101das kop\u0161anas uz\u0146\u0113mum\u0101 Galderma. Lai gan L’Or\u00e9al akciju cena nedaudz krit\u0101s, Galderma akciju v\u0113rt\u012bba C\u012brih\u0113 demonstr\u0113ja pret\u0113ju tendenci, pieaugot par gandr\u012bz 2%, lai gan iepriek\u0161 nov\u0113rots v\u0113l strauj\u0101ks k\u0101pums.<\/p>\n
Strat\u0113\u0123isk\u0101 invest\u012bcija un partner\u012bbas stiprin\u0101\u0161ana<\/p>\n
L’Or\u00e9al pl\u0101no ieg\u0101d\u0101ties 24 miljonus papildu akciju Galderma, t\u0101d\u0113j\u0101di palielinot savu \u012bpa\u0161umties\u012bbu da\u013cu l\u012bdz 20%. \u0160\u012bs akcijas tiks ieg\u0101d\u0101tas no konsorcija, ko vada Zviedrijas priv\u0101t\u0101 kapit\u0101la grupa EQT. Dar\u012bjuma finan\u0161u deta\u013cas netiek atkl\u0101tas, un t\u0101 nosl\u0113g\u0161ana paredz\u0113ta 2026. gada pirmaj\u0101 ceturksn\u012b. Papildus tam Galderma apsver iesp\u0113ju nomin\u0113t divus L’Or\u00e9al p\u0101rst\u0101vjus sav\u0101 vald\u0113, aizst\u0101jot pa\u0161reiz\u0113jo EQT vad\u012bto konsorciju. K\u0101 uzsv\u0113ris L’Or\u00e9al izpilddirektors Nikol\u0101 Hier\u016bnimuss, s\u0101kotn\u0113j\u0101 strat\u0113\u0123isk\u0101 invest\u012bcija Galderma 2024. gad\u0101 ir bijusi \u013coti veiksm\u012bga, motiv\u0113jot uz\u0146\u0113mumu cie\u0161\u0101k un pla\u0161\u0101k sadarboties. Lai gan L’Or\u00e9al stingri nor\u0101d\u012bjis, ka t\u0101l\u0101k\u0101 akciju da\u013cas palielin\u0101\u0161ana nav pl\u0101nota, \u0161\u012b strat\u0113\u0123isk\u0101 virz\u012bba skaidri signaliz\u0113 par uz\u0146\u0113muma amb\u012bcij\u0101m.<\/p>\n
Galderma k\u0101 inov\u0101ciju un zin\u0101tnes virz\u012bt\u0101jsp\u0113ks<\/p>\n
Galderma izpilddirektors Flemming \u00d8rnskov pau\u017e gandar\u012bjumu par L’Or\u00e9al palielin\u0101taj\u0101m invest\u012bcij\u0101m, nor\u0101dot, ka t\u0101s apstiprina uz\u0146\u0113muma virzienu un paredzamo v\u0113rt\u012bbas pieaugumu turpm\u0101kajos gados. Vi\u0146\u0161 uzsver Galderma nep\u0101rtraukto izaugsmi, sp\u0113c\u012bgo inov\u0101ciju un kategoriju l\u012bder\u012bbu pla\u0161aj\u0101, uz zin\u0101tni balst\u012btaj\u0101 dermatolo\u0123ijas produktu kl\u0101st\u0101. \u0160\u012b invest\u012bcija ir saska\u0146\u0101 ar L’Or\u00e9al pla\u0161\u0101ko strat\u0113\u0123iju, kas v\u0113rsta uz aesthetica jeb skaistuma est\u0113tikas tirgus izp\u0113ti, kas ir noz\u012bm\u012bga papildino\u0161a nozare uz\u0146\u0113muma pamatdarb\u012bbai.<\/p>\n
V\u0113sturisk\u0101 saikne un jaun\u0101k\u0101s akviz\u012bcijas<\/p>\n
Galderma v\u0113sture ir cie\u0161i saist\u012bta ar L’Or\u00e9al; uz\u0146\u0113mums tika dibin\u0101ts 1981. gad\u0101 kop\u012bgi ar \u0160veices p\u0101rtikas gigantu Nestl\u00e9. 2014. gad\u0101 Nestl\u00e9 piln\u012bb\u0101 p\u0101r\u0146\u0113ma savu partneru 50% da\u013cu, un 2019. gad\u0101 uz\u0146\u0113mums tika p\u0101rdots priv\u0101t\u0101 kapit\u0101la grupai EQT. Pag\u0101ju\u0161aj\u0101 gad\u0101 L’Or\u00e9al atkal ieg\u0101d\u0101j\u0101s 10% Galderma akciju, kuras v\u0113rt\u012bba tika l\u0113sta ap 1,7 miljardiem eiro. Toreiz \u0161\u012b kust\u012bba jau signaliz\u0113ja par interesi par modern\u0101k\u0101m skaistumkop\u0161anas tehnolo\u0123ij\u0101m, jo Galderma galvenok\u0101rt darbojas \u0101das est\u0113tikas tirg\u016b, pied\u0101v\u0101jot pla\u0161u dermo-kosm\u0113tikas, dermatolo\u0123isko z\u0101\u013cu un hialuronsk\u0101bes pildvielu kl\u0101stu. L’Or\u00e9al dermatolo\u0123ijas portfel\u012b jau ir iek\u013cauti t\u0101di popul\u0101ri z\u012bmoli k\u0101 La Roche-Posay un CeraVe, kuru popularit\u0101ti ir veicin\u0101jis pieaugo\u0161ais interese par zin\u0101tniski pamatotu \u0101das kop\u0161anu, kas akt\u012bvi tiek populariz\u0113ta soci\u0101lajos medijos.<\/p>\n
Diversifik\u0101cija un n\u0101kotnes perspekt\u012bvas<\/p>\n
\u0160\u012b jaun\u0101 vieno\u0161an\u0101s ar Galderma ir jaun\u0101k\u0101 no virknes akviz\u012bcij\u0101m, ko fran\u010du skaistumkop\u0161anas milzis veicis p\u0113d\u0113jos gados. Oktobr\u012b L’Or\u00e9al pazi\u0146oja par Kering skaistumkop\u0161anas biznesa ieg\u0101di, tostarp ar\u012b parfim\u0113rijas ra\u017eot\u0101ju House of Creed. L’Or\u00e9al ar\u012b vienoj\u0101s par 50 gadu licenc\u0113\u0161anas l\u012bgumiem attiec\u012bb\u0101 uz da\u017eiem Kering ikonisk\u0101kajiem z\u012bmoliem, \u012bpa\u0161i Gucci, Bottega Veneta un Balenciaga. Citi nesen ieg\u0101d\u0101tie z\u012bmoli ietver L’Or\u00e9al portfel\u012b ar\u012b Apvienot\u0101s Karalistes \u0101das kop\u0161anas z\u012bmolu Medik8 un Austr\u0101lijas ziepju ra\u017eot\u0101ju Aesop. \u0160\u012b dinamisk\u0101 strat\u0113\u0123ija liecina par L’Or\u00e9al ap\u0146em\u0161anos ne tikai nostiprin\u0101t savas poz\u012bcijas tradicion\u0101laj\u0101 skaistumkop\u0161anas tirg\u016b, bet ar\u012b akt\u012bvi papla\u0161in\u0101ties inovat\u012bv\u0101s un zin\u0101tniski balst\u012bt\u0101s jom\u0101s, piem\u0113ram, est\u0113tiskaj\u0101 dermatolo\u0123ij\u0101 un medic\u012bnas kosm\u0113tik\u0101.<\/p>\n","protected":false},"excerpt":{"rendered":"L’Or\u00e9al akciju v\u0113rt\u012bba samazin\u0101s, uz\u0146\u0113mumam veicot likmes uz Galderma un zin\u0101tniski balst\u012btu \u0101das kop\u0161anu Fran\u010du skaistumkop\u0161anas gigants L’Or\u00e9al…\n","protected":false},"author":2,"featured_media":70249,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[77,76,8563,35,39,38,36,37,34,40],"class_list":{"0":"post-70248","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-bizness","8":"tag-bizness","9":"tag-business","10":"tag-l","11":"tag-latvia","12":"tag-latvian","13":"tag-latviesu","14":"tag-latviesu-valoda","15":"tag-latviesuvaloda","16":"tag-latvija","17":"tag-lv"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@lv\/115691901558041439","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts\/70248","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/comments?post=70248"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts\/70248\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/media\/70249"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/media?parent=70248"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/categories?post=70248"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/tags?post=70248"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}